1. Home
  2. ICHR vs SUPN Comparison

ICHR vs SUPN Comparison

Compare ICHR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$57.83

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$43.58

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
SUPN
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
ICHR
SUPN
Price
$57.83
$43.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$49.50
★ $61.60
AVG Volume (30 Days)
★ 580.4K
539.7K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $947,652,000.00
$392,755,000.00
Revenue This Year
$20.51
$22.70
Revenue Next Year
$17.08
$19.14
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 11.61
N/A
52 Week Low
$14.06
$40.51
52 Week High
$113.58
$59.68

Technical Indicators

Market Signals
Indicator
ICHR
SUPN
Relative Strength Index (RSI) 48.69 49.16
Support Level $56.60 $42.54
Resistance Level $59.00 $52.33
Average True Range (ATR) 2.25 1.25
MACD 1.22 0.30
Stochastic Oscillator 85.41 76.76

Price Performance

Historical Comparison
ICHR
SUPN

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: